Abstract
We developed an adverse drug event (ADE) monitor based on published rules, and used it to detect admissions to the hospital due to ADEs. Over the study period, the ADE monitor identified 76 admissions to the hospital due to ADEs. Of these, 21 were determined to be preventable. The hospital-wide rate of admissions due to ADEs was 1.4/100 admissions and the preventable ADE admission rate was 0.4/100 admissions. The 76 events were associated with $1.2 million in costs. The computer monitor required 11 person hours a week to execute.
Full text
PDFPage 953
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bates D. W., Cullen D. J., Laird N., Petersen L. A., Small S. D., Servi D., Laffel G., Sweitzer B. J., Shea B. F., Hallisey R. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA. 1995 Jul 5;274(1):29–34. [PubMed] [Google Scholar]
- Bates D. W., Spell N., Cullen D. J., Burdick E., Laird N., Petersen L. A., Small S. D., Sweitzer B. J., Leape L. L. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997 Jan 22;277(4):307–311. [PubMed] [Google Scholar]
- Classen D. C., Pestotnik S. L., Evans R. S., Burke J. P. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991 Nov 27;266(20):2847–2851. [PubMed] [Google Scholar]
- Classen D. C., Pestotnik S. L., Evans R. S., Lloyd J. F., Burke J. P. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997 Jan 22;277(4):301–306. [PubMed] [Google Scholar]
- Lakshmanan M. C., Hershey C. O., Breslau D. Hospital admissions caused by iatrogenic disease. Arch Intern Med. 1986 Oct;146(10):1931–1934. [PubMed] [Google Scholar]